Andrew M. Fleming, MD, is a surgical oncologist and Complex General Surgical Oncology fellow at Moffitt Cancer Center in Tampa, Florida. His clinical focus includes hepatobiliary and pancreatic surgery, pediatric surgical oncology, and advanced operative strategies for complex oncologic care. Dr. Fleming’s research interests center on cancer epigenetics, mechanisms of treatment resistance, and surgical and multimodality approaches to improving outcomes in solid tumors. His work reflects a strong commitment to integrating scientific discovery with evidence-based surgical oncology. His achievements include recognition as an AASLD Emerging Liver Scholar, the Jens Rosenkrantz Resident Research Award from the AAP Section on Surgery, and a Best Basic Research Presentation honor at the International Pediatric Renal Tumour Biology Conference. He also served as chief resident during his general surgery training. Dr. Fleming earned his medical degree from the University of Tennessee Health Science Center College of Medicine, completed his general surgery residency at the University of Tennessee Health Science Center, and pursued a postdoctoral cancer biology research fellowship at St. Jude Children’s Research Hospital. He is currently completing fellowship training in complex general surgical oncology at Moffitt Cancer Center.
Fellow
2026 – present
Medical School
2015 – 2019
Residency
2019 – 2026
Fellowship
2021 – 2023